\-\ Texto\\:\\ \ \(0\)\
\-\ bp\\ 123\\/69\\,\\ bmi\\ 26\ \(0\)\
\-\ abdomen\\:\\ no\\ organomegaly\\,\\ masses\\,\\ tenderness\\.\\ \\ non\\-distended\\,\\ positive\\ bowel\\ sounds\\.\ \(0\)\
\-\ back\\ \\&\\ spine\\:\\ \\ no\\ costovertebral\\ angle\\ tenderness\\.\\ \\ no\\ point\\ tenderness\\.\ \(0\)\
\-\ extremities\\:\\ no\\ edema\ \(0\)\
\-\ neuro\\:\\ \\ a\\&o\\ x3\\,\\ no\\ focal\\ neurological\\ deficits\\.\\ \\ \ \(0\)\
\-\ the\\ rest\\ of\\ her\\ exam\\ was\\ non\\-contributory\\,\\ including\\ a\\ normal\\ ua\\.\ \(0\)\
\-\ there\\ is\\ no\\ specific\\ treatment\\ to\\ delay\\ or\\ prevent\\ the\\ progression\\ of\\ the\\ disease\\.\\ \\ symptomatic\\ treatment\\ of\\ pain\\ is\\ warranted\\ but\\ nonsteroidal\\ anti\\-inflammatory\\ drugs\\ are\\ discouraged\\ due\\ to\\ risk\\ of\\ exacerbation\\ of\\ renal\\ failure\\ \\ also\\,\\ tight\\ blood\\ pressure\\ control\\ is\\ needed\\ and\\ should\\ be\\ monitored\\ to\\ track\\ renal\\ failure\\ progression\\.\\ \\ many\\ deaths\\ from\\ adpkd\\ are\\ the\\ result\\ of\\ ascvd\\.\\ \\ in\\ addition\\,\\ lots\\ of\\ fluids\\ are\\ encouraged\\,\\ while\\ caffeine\\ should\\ be\\ avoided\\,\\ to\\ suppress\\ antidiuretic\\ hormone\\ secretion\\ and\\ prevent\\ stone\\ formation\\ \\(5\\)\\.\ \(0\)\
\-\ follow\\ up\\:\\ \ \(0\)\
\-\ \\â\\€\\¢genetic\\ counseling\\ with\\ possibility\\ of\\ testing\\ of\\ family\\ members\ \(0\)\
\-\ \\â\\€\\¢symptomatic\\ treatment\\ and\\ watching\\ renal\\ function\ \(0\)\
\-\ \\â\\€\\¢ultrasound\\ of\\ kidneys\\ for\\ baseline\\ and\\ anatomy\ \(0\)\
\-\ mri\\ showed\\ multiple\\ renal\\ cysts\\.\\ \\ the\\ largest\\ measures\\ 4\\.7\\ cm\\ in\\ maximal\\ dimension\\ and\\ is\\ in\\ the\\ upper\\ pole\\ of\\ the\\ right\\ kidney\\.\\ \\ additional\\ smaller\\ cysts\\ are\\ present\\ in\\ both\\ kidneys\\,\\ with\\ approximately\\ 4\\ moderate\\ sized\\ ones\\ in\\ the\\ right\\ kidney\\ and\\ 4\\ moderate\\ sized\\ ones\\ in\\ the\\ left\\ kidneys\\.\ \(0\)\
\-\ autosomal\\ dominant\\ polycystic\\ kidney\\ disease\\ \\(adpkd\\)\ \(0\)\
\-\ adpkd\\ \\(autosomal\\ dominant\\)\ \(0\)\
\-\ tuberous\\ sclerosis\\ \\(may\\ also\\ have\\ renal\\ angiomyolipoma\\)\ \(0\)\
\-\ von\\ hippel\\-lindau\\ \\(may\\ have\\ cns\\ hemangioblastoma\\)\ \(0\)\
\-\ other\\ cystic\\ disease\\ of\\ the\\ kidney\\:\ \(0\)\
\-\ acquired\\ renal\\ cystic\\ disease\\,\\ arpkd\\ \\(autosomal\\ recessive\\)\\,\\ medullary\\ cystic\\ disease\\,\\ simple\\ renal\\ cysts\\.\\ \\ arpkd\\ can\\ be\\ differentiated\\ from\\ adpkd\\ by\\ the\\ hepatic\\ fibrosis\\ that\\ is\\ always\\ present\\ in\\ patients\\ with\\ arpkd\\.\ \(0\)\
\-\ patient\\ had\\ chronic\\ lower\\ back\\/hip\\ pain\\ for\\ four\\ years\\ that\\ got\\ worse\\ 2\\ weeks\\ prior\\ to\\ admission\\.\\ \\ the\\ pain\\ is\\ reproducible\\ with\\ lifting\\,\\ walking\\,\\ standing\\ over\\ half\\ an\\ hour\\ and\\ sitting\\ too\\ long\\.\ \(0\)\
\-\ she\\ was\\ seen\\ by\\ orthopedics\\ who\\ think\\ the\\ back\\ pain\\ is\\ musculoskeletal\\,\\ however\\,\\ she\\ still\\ needs\\ interval\\ renal\\ function\\ tests\\ and\\ monitoring\\.\\ \\ the\\ fact\\ that\\ she\\ has\\ this\\ many\\ cysts\\ at\\ such\\ a\\ young\\ age\\ is\\ a\\ bad\\ prognostic\\ sign\\.\\ \\ also\\,\\ she\\ will\\ need\\ counseling\\ on\\ the\\ genetics\\ of\\ her\\ disease\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ renal\\:\\ 0\\.26666669980468954\ \(0\)\
\-\ adpkd\\:\\ 0\\.25993890218140386\ \(0\)\
\-\ arpkd\\:\\ 0\\.23101378142538123\ \(0\)\
\-\ autosomal\\:\\ 0\\.1656361792502697\ \(0\)\
\-\ cysts\\:\\ 0\\.16224771458534087\ \(0\)\
\-\ the\\:\\ 0\\.16021134183027175\ \(0\)\
\-\ kidney\\:\\ 0\\.15042124068512774\ \(0\)\
\-\ ones\\:\\ 0\\.13921193069966153\ \(0\)\
\-\ kidneys\\:\\ 0\\.13823258491062787\ \(0\)\
\-\ of\\:\\ 0\\.1361772568098514\ \(0\)\
\-\ disease\\:\\ 0\\.13481467135024602\ \(0\)\
\-\ counseling\\:\\ 0\\.12996945109070193\ \(0\)\
\-\ she\\:\\ 0\\.12745554037427953\ \(0\)\
\-\ is\\:\\ 0\\.1172718382300856\ \(0\)\
\-\ sized\\:\\ 0\\.10935140742075676\ \(0\)\
\-\ back\\:\\ 0\\.10709776179715136\ \(0\)\
\-\ no\\:\\ 0\\.10443998895422392\ \(0\)\
\-\ tenderness\\:\\ 0\\.10070586110423967\ \(0\)\
\-\ dominant\\:\\ 0\\.10018631906424932\ \(0\)\
\-\ prevent\\:\\ 0\\.09816637648993702\ \(0\)\
\-\ progression\\:\\ 0\\.09816637648993702\ \(0\)\
\-\ cystic\\:\\ 0\\.09671410409059902\ \(0\)\
\-\ in\\:\\ 0\\.09321203465400928\ \(0\)\
\-\ and\\:\\ 0\\.08848708575683627\ \(0\)\
\-\ function\\:\\ 0\\.08665205133747883\ \(0\)\
\-\ ascvd\\:\\ 0\\.08560276921529617\ \(0\)\
\-\ lots\\:\\ 0\\.08560276921529617\ \(0\)\
\-\ antidiuretic\\:\\ 0\\.08560276921529617\ \(0\)\
\-\ many\\:\\ 0\\.08440704507657164\ \(0\)\
\-\ symptomatic\\:\\ 0\\.08231963441716586\ \(0\)\
\-\ discouraged\\:\\ 0\\.0817980159862256\ \(0\)\
\-\ failure\\:\\ 0\\.08127896025916134\ \(0\)\
\-\ are\\:\\ 0\\.08124561831333875\ \(0\)\
\-\ moderate\\:\\ 0\\.08036700666439268\ \(0\)\
\-\ caffeine\\:\\ 0\\.07909850060939412\ \(0\)\
\-\ watching\\:\\ 0\\.07700459380846042\ \(0\)\
\-\ pain\\:\\ 0\\.0766170136997049\ \(0\)\
\-\ treatment\\:\\ 0\\.07649454077947053\ \(0\)\
\-\ also\\:\\ 0\\.07553397384286235\ \(0\)\
\-\ deaths\\:\\ 0\\.07384724733603437\ \(0\)\
\-\ nonsteroidal\\:\\ 0\\.0725942320034921\ \(0\)\
\-\ got\\:\\ 0\\.07148899415125301\ \(0\)\
\-\ suppress\\:\\ 0\\.07050032520255838\ \(0\)\
\-\ bad\\:\\ 0\\.07050032520255838\ \(0\)\
\-\ should\\:\\ 0\\.0698539060715975\ \(0\)\
\-\ that\\:\\ 0\\.06968730696440278\ \(0\)\
\-\ costovertebral\\:\\ 0\\.06960596534983077\ \(0\)\
\-\ avoided\\:\\ 0\\.06960596534983077\ \(0\)\
\-\ reproducible\\:\\ 0\\.06878947877442153\ \(0\)\
\-\ secretion\\:\\ 0\\.06803838393446013\ \(0\)\
\-\ think\\:\\ 0\\.06803838393446013\ \(0\)\
\-\ encouraged\\:\\ 0\\.06734297873013234\ \(0\)\
\-\ to\\:\\ 0\\.06690935244703404\ \(0\)\
\-\ her\\:\\ 0\\.06688239401730994\ \(0\)\
\-\ x3\\:\\ 0\\.06669557197348781\ \(0\)\
\-\ genetics\\:\\ 0\\.06608996339759006\ \(0\)\
\-\ members\\:\\ 0\\.0655210815850625\ \(0\)\
\-\ be\\:\\ 0\\.06514239039089378\ \(0\)\
\-\ tight\\:\\ 0\\.0644773762553596\ \(0\)\
\-\ prognostic\\:\\ 0\\.06268457580356378\ \(0\)\
\-\ bmi\\:\\ 0\\.0622852101685195\ \(0\)\
\-\ recessive\\:\\ 0\\.0622852101685195\ \(0\)\
\-\ fluids\\:\\ 0\\.061534115328558084\ \(0\)\
\-\ maximal\\:\\ 0\\.06117997231628041\ \(0\)\
\-\ organomegaly\\:\\ 0\\.060191303367585776\ \(0\)\
\-\ warranted\\:\\ 0\\.05988361429207316\ \(0\)\
\-\ lifting\\:\\ 0\\.05988361429207316\ \(0\)\
\-\ needs\\:\\ 0\\.05988361429207316\ \(0\)\
\-\ track\\:\\ 0\\.05958569479168803\ \(0\)\
\-\ von\\:\\ 0\\.059296943514858175\ \(0\)\
\-\ exacerbation\\:\\ 0\\.05874480332329658\ \(0\)\
\-\ sitting\\:\\ 0\\.05797310764945756\ \(0\)\
\-\ orthopedics\\:\\ 0\\.05772936209948752\ \(0\)\
\-\ monitored\\:\\ 0\\.05749178799075431\ \(0\)\
\-\ angiomyolipoma\\:\\ 0\\.05726008051307329\ \(0\)\
\-\ baseline\\:\\ 0\\.0565974281380267\ \(0\)\
\-\ polycystic\\:\\ 0\\.0565974281380267\ \(0\)\
\-\ dimension\\:\\ 0\\.05521205975008989\ \(0\)\
\-\ present\\:\\ 0\\.05493381065729637\ \(0\)\
\-\ hormone\\:\\ 0\\.05450352133709298\ \(0\)\
\-\ largest\\:\\ 0\\.05450352133709298\ \(0\)\
\-\ may\\:\\ 0\\.053873856805505875\ \(0\)\
\-\ too\\:\\ 0\\.05384474731550617\ \(0\)\
\-\ drugs\\:\\ 0\\.0535319291466369\ \(0\)\
\-\ hemangioblastoma\\:\\ 0\\.0535319291466369\ \(0\)\
\-\ have\\:\\ 0\\.05348024681387362\ \(0\)\
\-\ tuberous\\:\\ 0\\.05337934568617113\ \(0\)\
\-\ monitoring\\:\\ 0\\.05337934568617113\ \(0\)\
\-\ acquired\\:\\ 0\\.05159312796075002\ \(0\)\
\-\ fact\\:\\ 0\\.051346174864666944\ \(0\)\
\-\ tests\\:\\ 0\\.05122509349358549\ \(0\)\
\-\ ua\\:\\ 0\\.05110555460234024\ \(0\)\
\-\ differentiated\\:\\ 0\\.05110555460234024\ \(0\)\
\-\ anatomy\\:\\ 0\\.05075581190717125\ \(0\)\
\-\ hour\\:\\ 0\\.05075581190717125\ \(0\)\
\-\ musculoskeletal\\:\\ 0\\.05075581190717125\ \(0\)\
\-\ always\\:\\ 0\\.050529688289257704\ \(0\)\
\-\ half\\:\\ 0\\.0504186375723247\ \(0\)\
\-\ walking\\:\\ 0\\.05030888572397461\ \(0\)\
\-\ cns\\:\\ 0\\.049987128165973185\ \(0\)\
\-\ neuro\\:\\ 0\\.04988228153261318\ \(0\)\
\-\ possibility\\:\\ 0\\.04977859344929629\ \(0\)\
\-\ standing\\:\\ 0\\.04977859344929629\ \(0\)\
\-\ need\\:\\ 0\\.04927667295671544\ \(0\)\
\-\ delay\\:\\ 0\\.04908318824496851\ \(0\)\
\-\ stone\\:\\ 0\\.04889361258391855\ \(0\)\
\-\ simple\\:\\ 0\\.04843578148832398\ \(0\)\
\-\ interval\\:\\ 0\\.04843578148832398\ \(0\)\
\-\ smaller\\:\\ 0\\.04817143510447634\ \(0\)\
\-\ testing\\:\\ 0\\.04808494899859338\ \(0\)\
\-\ still\\:\\ 0\\.04742034026451493\ \(0\)\
\-\ medullary\\:\\ 0\\.04734047870960413\ \(0\)\
\-\ angle\\:\\ 0\\.04695105867810069\ \(0\)\
\-\ pole\\:\\ 0\\.0466507554164777\ \(0\)\
\-\ rest\\:\\ 0\\.0462884063030541\ \(0\)\
\-\ deficits\\:\\ 0\\.04600827576735638\ \(0\)\
\-\ control\\:\\ 0\\.045736266111492514\ \(0\)\
\-\ by\\:\\ 0\\.0454621037924935\ \(0\)\
\-\ fibrosis\\:\\ 0\\.044841906258764906\ \(0\)\
\-\ worse\\:\\ 0\\.044841906258764906\ \(0\)\
\-\ admission\\:\\ 0\\.0446608650922208\ \(0\)\
\-\ point\\:\\ 0\\.04425154330126922\ \(0\)\
\-\ needed\\:\\ 0\\.044194499502120385\ \(0\)\
\-\ young\\:\\ 0\\.04413780038059881\ \(0\)\
\-\ neurological\\:\\ 0\\.04396973004772205\ \(0\)\
\-\ measures\\:\\ 0\\.04364235931055879\ \(0\)\
\-\ 26\\:\\ 0\\.043482859560071155\ \(0\)\
\-\ bp\\:\\ 0\\.04343028980878396\ \(0\)\
\-\ four\\:\\ 0\\.04337801292671114\ \(0\)\
\-\ addition\\:\\ 0\\.043326025668739415\ \(0\)\
\-\ hepatic\\:\\ 0\\.04262691808674973\ \(0\)\
\-\ from\\:\\ 0\\.0425180270808546\ \(0\)\
\-\ formation\\:\\ 0\\.0424363800467376\ \(0\)\
\-\ family\\:\\ 0\\.04211197375299095\ \(0\)\
\-\ with\\:\\ 0\\.04192573005795262\ \(0\)\
\-\ additional\\:\\ 0\\.04149498412528891\ \(0\)\
\-\ sounds\\:\\ 0\\.0413259043065242\ \(0\)\
\-\ pressure\\:\\ 0\\.040757022493996625\ \(0\)\
\-\ extremities\\:\\ 0\\.04067849754987968\ \(0\)\
\-\ specific\\:\\ 0\\.04056192864633522\ \(0\)\
\-\ result\\:\\ 0\\.04007288897398193\ \(0\)\
\-\ including\\:\\ 0\\.038307220523920396\ \(0\)\
\-\ risk\\:\\ 0\\.03824668046836652\ \(0\)\
\-\ sclerosis\\:\\ 0\\.03812675965335138\ \(0\)\
\-\ was\\:\\ 0\\.03731000797059474\ \(0\)\
\-\ sign\\:\\ 0\\.03705800194484377\ \(0\)\
\-\ masses\\:\\ 0\\.036440770659783135\ \(0\)\
\-\ showed\\:\\ 0\\.03565336789443346\ \(0\)\
\-\ long\\:\\ 0\\.03549451105964354\ \(0\)\
\-\ right\\:\\ 0\\.035493428905686526\ \(0\)\
\-\ spine\\:\\ 0\\.035360456264592714\ \(0\)\
\-\ positive\\:\\ 0\\.03527213866147308\ \(0\)\
\-\ while\\:\\ 0\\.034594016080144695\ \(0\)\
\-\ will\\:\\ 0\\.03445199016365157\ \(0\)\
\-\ such\\:\\ 0\\.03443187509472209\ \(0\)\
\-\ bowel\\:\\ 0\\.03435184325724821\ \(0\)\
\-\ approximately\\:\\ 0\\.034154699954489054\ \(0\)\
\-\ age\\:\\ 0\\.03360534713145006\ \(0\)\
\-\ years\\:\\ 0\\.03281188799351674\ \(0\)\
\-\ abdomen\\:\\ 0\\.032660940887761246\ \(0\)\
\-\ for\\:\\ 0\\.03244779289901808\ \(0\)\
\-\ weeks\\:\\ 0\\.03208032214304392\ \(0\)\
\-\ focal\\:\\ 0\\.032017971906589525\ \(0\)\
\-\ edema\\:\\ 0\\.031925216527997076\ \(0\)\
\-\ chronic\\:\\ 0\\.031772633067531295\ \(0\)\
\-\ however\\:\\ 0\\.031682259886856155\ \(0\)\
\-\ blood\\:\\ 0\\.031086962528886784\ \(0\)\
\-\ due\\:\\ 0\\.030768841349951354\ \(0\)\
\-\ cm\\:\\ 0\\.030741681631823496\ \(0\)\
\-\ who\\:\\ 0\\.030278686157418147\ \(0\)\
\-\ patients\\:\\ 0\\.03011237261668527\ \(0\)\
\-\ prior\\:\\ 0\\.029948955507682867\ \(0\)\
\-\ both\\:\\ 0\\.02984978759859828\ \(0\)\
\-\ over\\:\\ 0\\.02976386713900933\ \(0\)\
\-\ follow\\:\\ 0\\.02885618765869068\ \(0\)\
\-\ upper\\:\\ 0\\.028604482130972796\ \(0\)\
\-\ can\\:\\ 0\\.028089747474242664\ \(0\)\
\-\ other\\:\\ 0\\.027797899172379795\ \(0\)\
\-\ mri\\:\\ 0\\.027476475626328684\ \(0\)\
\-\ lower\\:\\ 0\\.027352816676309906\ \(0\)\
\-\ exam\\:\\ 0\\.02694597291050119\ \(0\)\
\-\ had\\:\\ 0\\.026669569119196525\ \(0\)\
\-\ up\\:\\ 0\\.026478236379953553\ \(0\)\
\-\ but\\:\\ 0\\.026469631449444694\ \(0\)\
\-\ multiple\\:\\ 0\\.026181662113039635\ \(0\)\
\-\ seen\\:\\ 0\\.02520050310957366\ \(0\)\
\-\ has\\:\\ 0\\.024449986206733255\ \(0\)\
\-\ normal\\:\\ 0\\.021855083686656136\ \(0\)\
\-\ there\\:\\ 0\\.02129858629728338\ \(0\)\
\-\ an\\:\\ 0\\.02046889025136641\ \(0\)\
\-\ at\\:\\ 0\\.020218166433756905\ \(0\)\
\-\ or\\:\\ 0\\.018621404154466472\ \(0\)\
\-\ this\\:\\ 0\\.018393151270362184\ \(0\)\
\-\ left\\:\\ 0\\.018259534999200914\ \(0\)\
\-\ patient\\:\\ 0\\.017409939533837845\ \(0\)\
\-\ on\\:\\ 0\\.01616634535796507\ \(0\)\
